These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29488412)

  • 1. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of
    Cuffaro B; Assohoun ALW; Boutillier D; Súkeníková L; Desramaut J; Boudebbouze S; Salomé-Desnoulez S; Hrdý J; Waligora-Dupriet AJ; Maguin E; Grangette C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.
    Rong J; Zheng H; Liu M; Hu X; Wang T; Zhang X; Jin F; Wang L
    BMC Microbiol; 2015 Oct; 15():196. PubMed ID: 26428623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model.
    Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L
    Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.
    Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I
    PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
    Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
    Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
    Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ
    Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice.
    Holowacz S; Blondeau C; Guinobert I; Guilbot A; Hidalgo S; Bisson JF
    Benef Microbes; 2018 Feb; 9(2):299-309. PubMed ID: 29409331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy: A Novel Mechanism Involved in the Anti-Inflammatory Abilities of Probiotics.
    Zaylaa M; Alard J; Kassaa IA; Peucelle V; Boutillier D; Desramaut J; Rosenstiel P; Nguyen HTT; Dabboussi F; Pot B; Grangette C
    Cell Physiol Biochem; 2019; 53(5):774-793. PubMed ID: 31647207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.
    Elian SD; Souza EL; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
    Benef Microbes; 2015; 6(3):277-86. PubMed ID: 25391346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect.
    Presti I; D'Orazio G; Labra M; La Ferla B; Mezzasalma V; Bizzaro G; Giardina S; Michelotti A; Tursi F; Vassallo M; Di Gennaro P
    Appl Microbiol Biotechnol; 2015 Jul; 99(13):5613-26. PubMed ID: 25744647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
    Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B
    Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.
    Foligné B; Nutten S; Steidler L; Dennin V; Goudercourt D; Mercenier A; Pot B
    Dig Dis Sci; 2006 Feb; 51(2):390-400. PubMed ID: 16534687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: Reverse engineering development of an anti-inflammatory cheese.
    Plé C; Breton J; Richoux R; Nurdin M; Deutsch SM; Falentin H; Hervé C; Chuat V; Lemée R; Maguin E; Jan G; Van de Guchte M; Foligné B
    Mol Nutr Food Res; 2016 Apr; 60(4):935-48. PubMed ID: 26640113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.
    Feighery LM; Smith P; O'Mahony L; Fallon PG; Brayden DJ
    Dig Dis Sci; 2008 Sep; 53(9):2495-506. PubMed ID: 18157694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological Characteristics of
    Liu Y; Li Y; Yu X; Yu L; Tian F; Zhao J; Zhang H; Zhai Q; Chen W
    J Microbiol Biotechnol; 2021 Jan; 31(1):92-103. PubMed ID: 32522964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.